The statistics are staggering – according to the CDC, 19.7% of young people aged 2-19 suffer from obesity – but the solution, ...

Researchers at Treated, a weight loss company, say that America's obesity rate could drop by another 10.6 percent over the ...

and -0.87 ± 1.92 (CDC growth references). No significant secular trends in BMI z-scores, gender, or DKA presentation were observed. Of 59(14.46%) children with baseline overweight/obesity, 46 (77.97%) ...

How do obesity biotechs compete against Novo Nordisk and Eli Lilly? Why does gene therapy pioneer Jim Wilson think there’s “irrational pessimism” in the field? And why isn’t Immunovant ...

Shares in Novo Nordisk fell on Monday on a second set of worse than expected trial results for the latest obesity drug from the manufacturer of blockbuster treatments Ozempic and Wegovy.

A new study claims there are two kinds of obesity – one of which puts you at risk of major health problems. Find out which camp you’re in ...

Novo Nordisk reported the second Phase 3 trial of its new obesity hopeful CagriSema and, as with the first, the topline weight loss result was disappointing, Pharmaphorum notes. The drug ...

LONDON/COPENHAGEN, March 10 (Reuters) - Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate CagriSema, knocking shares and ...